18 Members•4,119 Posts

Health

Cizzle Biotechnology rises as US patent granted for lung cancer test

Jun 12, 2026

Oliver Haill

Allergy Therapeutics to showcase pollen and food allergy progress

Jun 12, 2026

Jamie Ashcroft

BSF Enterprise says 'T-Rex' auction sharpened interest in bio-leather

Jun 12, 2026

Proactive

Lumos Diagnostics expands FebriDx adoption across 100+ US healthcare sites with CLIA Waiver

Jun 11, 2026

Steve Darling

Poolbeg Pharma launches POLB 001 TOPICAL trial to tackle CAR-T side effects

Jun 11, 2026

Stephen Gunnion

FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI

Jun 11, 2026

Jonathan Jackson

Prescient appoints oncology drug development veteran Dr Rosalind Wilson as chief medical officer

Jun 11, 2026

Jonathan Jackson

Medicus Pharma files IND for genomics-enabled endometriosis trial in UAE

Jun 11, 2026

Angela Harmantas

BSF Enterprise secures £1m as it advances commercial work for its tissue generation businesses

Jun 11, 2026

Jamie Ashcroft

Poolbeg Pharma shows clinical progress with latest updates

Jun 11, 2026

Jamie Ashcroft

Atossa Therapeutics highlights Endoxifen progress as potential Breast Cancer treatment

Jun 10, 2026

Steve Darling

Smith & Nephew's robotics push wins backing from surgeons and Citi

Jun 10, 2026

Oliver Haill

GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts

Jun 10, 2026

Oliver Haill

Immunic to showcase IMU-856 research at June conferences

Jun 10, 2026

Angela Harmantas

Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share

Jun 10, 2026

Angela Harmantas

Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions

Jun 9, 2026

Lisa Uhlman

Noxopharm unveils new cancer immunotherapy potential - ICYMI

Jun 9, 2026

Jonathan Jackson

Small Cap Watch: Pilbara ramps up Mt York drilling, AuKing begins Tundulu campaign

Jun 9, 2026

Lisa Uhlman

The Morning Catch-Up: ASX set for cautious rise as tech steadies and markets assess weekend risks

Jun 9, 2026

Lisa Uhlman

France clearance marks key milestone for Anteris' pivotal PARADIGM Trial

Jun 9, 2026

Jonathan Jackson

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy